Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Diagnosis and management of Stevens-Johnson syndrome/toxic epidermal necrolysis.

Clinics in dermatology - 1 Jan 2000

Noe Megan H, Micheletti Robert G

Abstract excerpt

Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) is a rare, immunologically mediated cutaneous adverse reaction characterized by mucous membrane and epidermal detachment, with a mortality ranging from 15% to 25%. Risk factors for the development of SJS/TEN include immune dysregulation, active malignancy, and genetic predisposition. Medications are the most common cause, particularly antimicrobials,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Infective Agents
Share to Anti-Inflammatory Agents, Non-Steroidal
Share to Anticonvulsants

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Antigens, Differentiation, T-Lymphocyte

Share to Fas Ligand Protein

Share to Immune System Diseases

Share to Perforin

Share to Stevens-Johnson Syndrome

Source

Identifiers

PMID: 33341195
DOI: 10.1016/j.clindermatol.2020.06.016

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Diagnosis and management of Stevens-Johnson syndrome/toxic epidermal necrolysis.PMID 33341195Read ↗

Update on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Diagnosis and Management.Semantic proximity Read ↗

Stevens-Johnson syndrome and toxic epidermal necrolysis: clinical patterns, diagnostic considerations, etiology, and therapeutic management.Semantic proximity Read ↗

Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis- An OverviewSemantic proximity Read ↗

[Recent progress in research of pathogeneses of Stevens-Johnson syndrome and toxic epidermal necrolysis].Semantic proximity Read ↗

Toxic epidermal necrolysis and Stevens-Johnson syndrome.Semantic proximity Read ↗

Recent advances in the genetics and immunology of Stevens-Johnson syndrome and toxic epidermal necrosis.Semantic proximity Read ↗

Stevens-Johnson syndrome and toxic epidermal necrolysis.Semantic proximity Read ↗

A Review of the Pathogenesis of Toxic Epidermal Necrolysis.Semantic proximity Read ↗

Genetic markers and danger signals in stevens-johnson syndrome and toxic epidermal necrolysis.Semantic proximity Read ↗

Current Pharmacogenetic Perspective on Stevens-Johnson Syndrome and Toxic Epidermal NecrolysisSemantic proximity Read ↗

Advances in Prognostic Biomarkers and Targeted Immunomodulation in Severe Cutaneous Adverse ReactionsSemantic proximity Read ↗

Stevens Johnson syndrome: A review of a vision and life-threatening mucocutaneous disease including histopathology with updates on pathogenesis and genetic risk factors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.